Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-067-2013

Drug recall · December 5, 2012

Pradaxa recall

Why: Defective container; damaged bottles could allow moisture to get into the bottle and thus may impair the quality of the product

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Pradaxa (dabigatran etexilate), 75 mg Capsules, 60 count bottles, Rx only, Distributed by Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT --- NDC 0597-0149-54

Lots / codes

Lot 201900 Expiration Date: JAN 2015

Quantity
8,381 bottles
Company
Boehringer Ingelheim Roxane Inc, Columbus, OH
Distribution
Nationwide
Initiated
November 5, 2012 · Voluntary: Firm initiated
Classified
November 26, 2012
Reported
December 5, 2012
Ended
September 18, 2013
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Dabigatran etexilate

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.